Prednisone Clinical Trials

• Alternate Day Prednisone or Daily Fish Oil Supplements in Patients with Immunoglobulin A Nephropathy
  ClinicalTrials.gov Identifier: NCT00004448 - Active, not recruiting
  IGA Glomerulonephritis
  
• Phase II Study of Irofulven in Patients with Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00124566 - Active, not recruiting
  Prostate Cancer
  
• XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (TROPIC)
  ClinicalTrials.gov Identifier: NCT00417079 - Recruiting
  Neoplasms; Prostatic Neoplasms
  
• VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients with Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00111319 - Active, not recruiting
  Multiple Myeloma
  
• Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002653 - Active, not recruiting
  Multiple Myeloma
  
• GVAX® Prostate Cancer Vaccine vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089856 - Active, not recruiting
  Prostate Cancer
  
• AIRSAC Trial - Comparison of a Tacrolimus/Sirolimus/Prednisone Regimen Versus Tacrolimus/Azathioprine/Prednisone Immunosuppressive Regimen in Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00321906 - Recruiting
  Delayed Graft Function; Graft Rejection
  
• High-dose Prednisone in Duchenne Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00110669 - Active, not recruiting
  Duchenne Muscular Dystrophy
  
• Phase I/II Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients with Advanced Stages Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00147875 - Active, not recruiting
  Hodgkin''s Disease
  
• Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089609 - Recruiting
  Prostatic Neoplasms
  
• Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone OR Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab Followed by Vaccine Therapy Plus Sargramostim in Treating Patients With Stage II, Stage III, or Stage IV Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00019981 - Recruiting
  Lymphoma
  
• Adjuvant Therapy for High Risk Prostate Carcinoma: A Phase III Randomized Study of Observation Vs. Deocetaxel and Prednisone
  ClinicalTrials.gov Identifier: NCT00132301 - Recruiting
  Prostate Cancer
  
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
  ClinicalTrials.gov Identifier: NCT00571675 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
  ClinicalTrials.gov Identifier: NCT00003283 - Active, not recruiting
  recurrent malignant thymoma; invasive malignant thymoma
  
• Docetaxel in Combination with GVAX ® Vaccine for Prostate Cancer Vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer With Pain
  ClinicalTrials.gov Identifier: NCT00133224 - Recruiting
  Prostate Cancer
  
• Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00227591 - Active, not recruiting
  Chronic Myeloproliferative Disorders
  
• The Prednisone-Sparing Effect of Anti-IL-5 Antibody (SB-240563)
  ClinicalTrials.gov Identifier: NCT00292877 - Active, not recruiting
  Asthma
  
• Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003584 - Active, not recruiting
  Stage IV Renal Cell Cancer; childhood kidney/urinary cancer; recurrent renal cell cancer
  
• Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
  ClinicalTrials.gov Identifier: NCT00493766 - Active, not recruiting
  Hormone Refractory Prostate Cancer
  
• Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
  ClinicalTrials.gov Identifier: NCT00004482 - Active, not recruiting
  Myocarditis; Giant Cell Myocarditis
  
• Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079261 - Active, not recruiting
  adult diffuse large cell lymphoma; adult lymphomatoid granulomatosis; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; ...
  
• Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
  
• Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
  ClinicalTrials.gov Identifier: NCT00066469 - Recruiting
  post-transplant lymphoproliferative disorder
  
• Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
  ClinicalTrials.gov Identifier: NCT00445900 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
  
• Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006890 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Prednisolone Pharmacokinetics in the Presence and Absence of Ritonavir After Oral Prednisone Administration to Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00072644 - Active, not recruiting
  Healthy
  
• Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00228020 - Active, not recruiting
  Pediatric Kidney Transplantation
  
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
  ClinicalTrials.gov Identifier: NCT00450970 - Active, not recruiting
  Prostate Cancer
  
• UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00045500 - Active, not recruiting
  Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
  ClinicalTrials.gov Identifier: NCT00551291 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Docetaxel and Prednisone With or Without OGX-011 in Treating Patients With Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00258388 - Active, not recruiting
  Prostate Cancer
  
• Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00182741 - Active, not recruiting
  Prostate Cancer
  
• Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00293371 - Active, not recruiting
  Prostate Cancer
  
• Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
  ClinicalTrials.gov Identifier: NCT00388635 - Active, not recruiting
  Multiple Myeloma
  
• CoQ10 and Prednisone in Non-Ambulatory DMD
  ClinicalTrials.gov Identifier: NCT00308113 - Recruiting
  Duchenne Muscular Dystrophy
  
• Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049673 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00033293 - Recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00110214 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Prednisone and Either Cyclosporine or Tacrolimus With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00089141 - Recruiting
  Cancer; Graft Versus Host Disease
  
• Melphalan and Prednisone With or Without Bortezomib in Treating Older Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00109902 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
  ClinicalTrials.gov Identifier: NCT00440349 - Active, not recruiting
  Retroperitoneal Fibrosis
  
• Docetaxel, Bevacizumab, Thalidomide, and Prednisone in Treating Patients With Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00091364 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00080847 - Active, not recruiting
  contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ...
  
• Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00070447 - Active, not recruiting
  contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma
  
• Phase 2 Study of CP-751,871 in Combination With Docetaxel and Prednisone in HRPC
  ClinicalTrials.gov Identifier: NCT00313781 - Recruiting
  Prostatic Neoplasms
  
• Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00486421 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Etanercept, Mycophenolate Mofetil, Denileukin Diftitox, or Pentostatin Combined With Prednisone or Methylprednisolone in Treating Patients With Acute Graft-Versus-Host Disease Who Have Undergone a Previous Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00253656 - Recruiting
  Cancer; Graft Versus Host Disease
  
• Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00134056 - Recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer; bone metastases
  
• Steroid Withdrawal in Pediatric Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00023244 - Active, not recruiting
  End-Stage Renal Disease
  
• Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination with Prednisone
  ClinicalTrials.gov Identifier: NCT00119678 - Completed
  Systemic Lupus Erythematosus
  
• Pediatric Kidney Transplant without Calcineurin Inhibitors
  ClinicalTrials.gov Identifier: NCT00023231 - Active, not recruiting
  End-Stage Renal Disease
  
• Suppressing the Immune System With or Without Steroids in Children Who Have Received Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00141037 - Active, not recruiting
  Kidney Diseases; Kidney Transplantation
  
• Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004197 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002715 - Active, not recruiting
  adult Hodgkin's lymphoma
  
• MEDI-522 in the Treatment of Patients with Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00072930 - Active, not recruiting
  Prostate Cancer
  
• Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003343 - Active, not recruiting
  stage IV prostate cancer
  
• Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
  ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
  Lymphoma
  
• Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
  ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
  Lymphoma; Multiple Myeloma
  
• Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00295932 - Recruiting
  Leukemia; Lymphoma
  
• A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV co-Infection
  ClinicalTrials.gov Identifier: NCT00414414 - Recruiting
  Tuberculosis; HIV Infections
  
• Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00018954 - Active, not recruiting
  Lymphoma; Leukemia
  
• Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00184002 - Recruiting
  Non-Hodgkin's Lymphoma
  
• PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
  ClinicalTrials.gov Identifier: NCT00544219 - Recruiting
  Lymphoma
  
• Optic Neuritis Treatment Trial (ONTT)
  ClinicalTrials.gov Identifier: NCT00000146 - Active, not recruiting
  Multiple Sclerosis; Optic Neuritis
  
• Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00075725 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
  Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003389 - Active, not recruiting
  adult Hodgkin's lymphoma
  
• Longitudinal Optic Neuritis Study (LONS)
  ClinicalTrials.gov Identifier: NCT00000147 - Active, not recruiting
  Multiple Sclerosis; Optic Neuritis
  
• Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00060346 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002499 - Active, not recruiting
  recurrent childhood acute lymphocytic leukemia
  
• Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00527124 - Recruiting
  Prostate Cancer
  
• Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00286793 - Recruiting
  Prostate Cancer
  
• Ixabepilone, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00331344 - Recruiting
  Prostate Cancer
  
• Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00477750 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Azacitidine, Docetaxel, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00503984 - Recruiting
  Pain; Prostate Cancer
  
• Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00540644 - Recruiting
  Multiple Myeloma
  
• Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00348816 - Recruiting
  Prostate Cancer
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• A Multicenter, Open-Label Study of YM155 + Docetaxel + Prednisone in Men With Advanced Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00514267 - Recruiting
  Prostate Cancer
  
• Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00255606 - Recruiting
  Prostate Cancer
  
• Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
  ClinicalTrials.gov Identifier: NCT00294658 - Recruiting
  Myasthenia Gravis
  
• ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00350051 - Recruiting
  Prostate Cancer
  
• A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
  ClinicalTrials.gov Identifier: NCT00580229 - Recruiting
  Rheumatoid Arthritis
  
• Alemtuzumab Combined With Etoposide, Vincristine, Doxorubicin, Cyclophosphamide, and Prednisone in Treating Patients Who Have Not Received Chemotherapy For T-Cell or NK-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00072254 - Recruiting
  Lymphoma
  
• Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00406978 - Recruiting
  Multiple Myeloma
  
• Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00232934 - Completed
  Multiple Myeloma
  
• Clinical Study of Abiraterone Acetate and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00485303 - Recruiting
  Hormone Refractory Prostate Cancer
  
• TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002757 - Active, not recruiting
  Burkitt's Lymphoma; Lymphoblastic Leukemia; Lymphocytic Lymphoma
  
• Sudden Hearing Loss Multicenter Treatment Trial
  ClinicalTrials.gov Identifier: NCT00097448 - Recruiting
  Sudden Deafness
  
• Phase II Study of Hyper-CVAD plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00038610 - Active, not recruiting
  Leukemia, Lymphocytic, Acute, L2
  
• Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003232 - Active, not recruiting
  Pain; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Prednisone TRT Study
  ClinicalTrials.gov Identifier: NCT00146640 - Completed
  Rheumatoid Arthritis
  
• Study Of Su011248 In Combination With Docetaxel (Taxotere.) And Prednisone In Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00137436 - Recruiting
  Prostatic Neoplasms
  
• Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
  ClinicalTrials.gov Identifier: NCT00004686 - Active, not recruiting
  Giant Cell Arteritis
  
• Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond to Previous Systemic Treatment
  ClinicalTrials.gov Identifier: NCT00079183 - Active, not recruiting
  Graft Versus Host Disease
  
• The Effects of Prednisone on HIV Levels and the Immune System
  ClinicalTrials.gov Identifier: NCT00000921 - Completed
  HIV Infections
  
• Combination Chemotherapy in Treating Children With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002590 - Active, not recruiting
  stage IV childhood large cell lymphoma; stage IV childhood lymphoblastic lymphoma
  
• Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003633 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070018 - Recruiting
  adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Mantle Cell Lymphoma